Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1995-06-07
1997-04-22
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 185, 424 961, 540145, 540122, 540121, 514410, A61K 5102, C07D48722
Patent
active
056226853
ABSTRACT:
Tumor-active or tumor-diagnostic substances having preferred accumulation in the tumor, which are characterized in that they have
REFERENCES:
patent: 5053423 (1991-10-01), Liu
patent: 5109016 (1992-04-01), Dixon et al.
patent: 5162231 (1992-11-01), Cole et al.
patent: 5162519 (1992-11-01), Bonnett et al.
patent: 5284647 (1994-02-01), Niedballa et al.
Sigma Catalogue, p. 671, 1994.
Inada et al., JP 63154689 as abstracted in Chemical Abstracts, CA 111(9): 956a, 1988.
Suzuki et al., "Preparation of Cyclotriphosphazene derivatives Bound to Hydrophilic Polymer & Therapeutic Physiologically Active Substrate" Chemical Abstract vol. 112, No. 3, 1990, p. 519. AB. #21146y.
Friedrich Eckhard
Graschew Georgi
Klenner Thomas
Maier-Borst Wolfgang
Schrenk Hans-Hermann
Chapman Lara E.
Deutches Krebsforchunszentrum Stiftung des Offentlichen Rechts
Hollinden Gary E.
LandOfFree
Polyether-substituted porphyrin anti-tumor agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polyether-substituted porphyrin anti-tumor agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyether-substituted porphyrin anti-tumor agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-339677